Helus Pharma <HELP.O>: Barclays initiates coverage with Overweight rating; target price $35
HELP•Related News
Solidion Technology CEO Jaymes Winters lifts stake to 4,709 shares with USD 7.11 purchase
STI•
Fed, BoE probe banks' exposure to trading firms after Jane Street loss, FT reports
XLF•
Trilogy Metals says USACE starts NEPA environmental review for Arctic copper-zinc project in Alaska
TMQ•
Aerospace suppliers test rare-earth alternatives to ease reliance on China
XLI•
HubSpot, Inc. <HUBS.N>: Stephens Raises Target Price to $255 From $251
HUBS•